Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

ADMA

ADMA BIOLOGICS, INC.

CIK 0001368514 · Nasdaq

NasdaqHealth CareBiological Products, (No Diagnostic Substances)
$9.84
↑ 0.08 (0.82%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: BullishOverall score · based on 4/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Fundamentals, Ownership, Options

Key stats

Market Cap
$2.20B
P/E Ratio
13.04
EPS
0.62
Dividend Yield
Not covered
52W Position
20%
Beta
0.84

Valuation multiples

Fwd P/E
12.00
PEG
0.00
P/B
5.40
P/S
4.30
EV/Revenue
4.42
ROE
41.4%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 20%
$7.21$20.46

Latest Financials

2025-12-31 FY
Revenue
$510.17M
Net Income
$146.93M
Total Assets
$624.24M
Free Cash Flow
$27.82M

Recent news